9
views
0
recommends
+1 Recommend
0 collections
    0
    shares
      • Record: found
      • Abstract: found
      • Article: found
      Is Open Access

      Adipogenesis as a Potential Anti-Obesity Target: A Review of Pharmacological Treatment and Natural Products

      review-article

      Read this article at

          There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

          Abstract

          Obesity is recognized as a severe threat to overall human health and is associated with type 2 diabetes mellitus, dyslipidemia, hypertension, and cardiovascular diseases. Abnormal expansion of white adipose tissue involves increasing the existing adipocytes’ cell size or increasing the number through the differentiation of new adipocytes. Adipogenesis is a process of proliferation and differentiation of adipocyte precursor cells in mature adipocytes. As a key process in determining the number of adipocytes, it is a possible therapeutic approach for obesity. Therefore, it is necessary to identify the molecular mechanisms involved in adipogenesis that could serve as suitable therapeutic targets. Reducing bodyweight is regarded as a major health benefit. Limited efficacy and possible side effects and drug interactions of available anti-obesity treatment highlight a constant need for finding novel efficient and safe anti-obesity ingredients. Numerous studies have recently investigated the inhibitory effects of natural products on adipocyte differentiation and lipid accumulation. Possible anti-obesity effects of natural products include the induction of apoptosis, cell-cycle arrest or delayed progression, and interference with transcription factor cascade or intracellular signaling pathways during the early phase of adipogenesis.

          Related collections

          Most cited references167

          • Record: found
          • Abstract: found
          • Article: found

          High prevalence of obesity in severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) requiring invasive mechanical ventilation

          Abstract Objective The Covid‐19 pandemic is rapidly spreading worldwide, notably in Europe and North America, where obesity is highly prevalent. The relation between obesity and severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has not been fully documented. Methods In this retrospective cohort study we analyzed the relationship between clinical characteristics, including body mass index (BMI), and the requirement for invasive mechanical ventilation (IMV) in 124 consecutive patients admitted in intensive care for SARS‐CoV‐2, in a single French center. Results Obesity (BMI >30 kg/m2) and severe obesity (BMI >35 kg/m2) were present in 47.6% and 28.2% of cases, respectively. Overall, 85 patients (68.6%) required IMV. The proportion of patients who required IMV increased with BMI categories (p 35 kg/m2 (85.7%). In multivariate logistic regression, the need for IMV was significantly associated with male sex (p 35 kg/m2 vs patients with BMI <25 kg/m2 was 7.36 (1.63‐33.14; p=0.02) Conclusion The present study showed a high frequency of obesity among patients admitted in intensive care for SARS‐CoV‐2. Disease severity increased with BMI. Obesity is a risk factor for SARS‐CoV‐2 severity requiring increased attention to preventive measures in susceptible individuals.
            Bookmark
            • Record: found
            • Abstract: found
            • Article: not found

            Obesity in patients younger than 60 years is a risk factor for Covid-19 hospital admission

            Abstract
              Bookmark
              • Record: found
              • Abstract: found
              • Article: found
              Is Open Access

              The growing use of herbal medicines: issues relating to adverse reactions and challenges in monitoring safety

              The use of herbal medicinal products and supplements has increased tremendously over the past three decades with not less than 80% of people worldwide relying on them for some part of primary healthcare. Although therapies involving these agents have shown promising potential with the efficacy of a good number of herbal products clearly established, many of them remain untested and their use are either poorly monitored or not even monitored at all. The consequence of this is an inadequate knowledge of their mode of action, potential adverse reactions, contraindications, and interactions with existing orthodox pharmaceuticals and functional foods to promote both safe and rational use of these agents. Since safety continues to be a major issue with the use of herbal remedies, it becomes imperative, therefore, that relevant regulatory authorities put in place appropriate measures to protect public health by ensuring that all herbal medicines are safe and of suitable quality. This review discusses toxicity-related issues and major safety concerns arising from the use of herbal medicinal products and also highlights some important challenges associated with effective monitoring of their safety.
                Bookmark

                Author and article information

                Journal
                Diabetes Metab Syndr Obes
                Diabetes Metab Syndr Obes
                dmso
                dmso
                Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy
                Dove
                1178-7007
                08 January 2021
                2021
                : 14
                : 67-83
                Affiliations
                [1 ]Faculty of Medicine, Josip Juraj Strossmayer University of Osijek , Osijek, Croatia
                [2 ]Faculty of Dental Medicine and Health Osijek, Josip Juraj Strossmayer University of Osijek , Osijek, Croatia
                [3 ]Department of Internal Medicine, General Hospital “Dr. Josip Benčević” , Slavonski Brod, Croatia
                [4 ]Department of Cardiology, University Hospital Osijek , Osijek, Croatia
                [5 ]Special Hospital Radiochirurgia Zagreb , Zagreb, Croatia
                Author notes
                Correspondence: Jelena Jakab Faculty of Medicine, Josip Juraj Strossmayer University of Osijek , Crkvena 21, Osijek31 000, CroatiaTel +385 91 224 1502 Email jelena.jakab@fdmz.hr
                Author information
                http://orcid.org/0000-0002-5023-4409
                Article
                281186
                10.2147/DMSO.S281186
                7802907
                d218acb7-42a0-4d10-82b9-652a2a09ae49
                © 2021 Jakab et al.

                This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License ( http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms ( https://www.dovepress.com/terms.php).

                History
                : 10 September 2020
                : 09 December 2020
                Page count
                Figures: 1, Tables: 1, References: 167, Pages: 17
                Funding
                Funded by: received no external funding;
                This research received no external funding.
                Categories
                Review

                Endocrinology & Diabetes
                adipogenesis,transcriptional cascades,signaling pathways,anti-obesity treatment,bioactive molecules

                Comments

                Comment on this article